Abstract Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) is a glycoprotein
involved in homotypic and heterotypic cell adhesion. ALCAM can be proteolytically cleaved …

Background: CD44 is widely used as a putative cancer stem cells (CSCs) marker for
colorectal cancer (CRC). However, the prognostic role of CD44 in CRC remains …

Background Although the unconjugated secondary bile acids, specifically deoxycholic acid
(DCA) and lithocholic acid (LCA), are considered to be risk factors for colorectal cancer, the …

The most commonly mutated isoform of RAS among all cancer subtypes is KRAS. In this
review, we focus on the special role of KRAS mutations in colorectal cancer (CRC), aiming …

Colorectal cancer (CRC) represents the third cause of cancer‐related mortalities worldwide.
The progression of CRC to the metastatic phase significantly compromises the overall …

The interest in liquid biopsy is growing because it could represent a non-invasive prognostic
or predictive tool for clinical outcome in patients with pancreatic ductal adenocarcinoma …

Colorectal cancer (CRC) is a leading cause of cancer death worldwide, and about 20% is
metastatic at diagnosis and untreatable. Increasing evidence suggests that the …

Simple Summary ALCAM (activated leukocyte cell adhesion molecule) is an important
regulator in human cancers, particularly solid tumours. Its expression in cancer tissues has …

K-Ras is a well-studied oncogene, and its mutation is frequently found in epithelial cancers
like pancreas, lung, and colorectal cancers. Cancer cells harboring K-Ras mutations are …

Objective: Cancer stem cell marker CD44 and its variant isoforms (CD44v) may be
correlated with tumor growth, metastasis, and chemo-radiotherapy resistance. However, the …